<p>Compounds of formula (I) and methods are provided for the treatment of disease or conditions in which modification of cholinergic, especially muscarinic receptor activity, has a beneficial effect.</p>
申请公布号
AU2014240139(A1)
申请公布日期
2015.09.17
申请号
AU20140240139
申请日期
2014.03.14
申请人
ACADIA PHARMACEUTICALS INC.
发明人
BURSTEIN, ETHAN S.;ESKILDSEN, JORGEN;OLSSON, ROGER;LUHRS, LAUREN M.;WHEELER, LARRY A.;GIL, DANIEL W.
